Loading clinical trials...
Loading clinical trials...
Cystic Fibrosis (CF) is a genetic disease that affects multiple organs and systems. In recent years, the marketing of CFTR protein modulator drugs, such as the Elexacaftor-Tezacaftor-Ivacaftor (ETI) c...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Meyer Children's Hospital IRCCS
NCT06984679 · Cystic Fibrosis (CF), Cystic Fibrosis in Children
NCT07484607 · Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation
NCT06940531 · Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation
NCT06616857 · Cystic Fibrosis (CF)
NCT07108153 · Cystic Fibrosis (CF)
Centro per la Fibrosi Cistica, Azienda Universitaria Ospedaliera Consorziale Policlinico
Bari, Bari
Dipartimento di Pediatria, Centro Fibrosi Cistica, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Milano
Unità Pediatrica, Dipartimento di Scienze Mediche Traslazionali, Centro di Riferimento Regionale per la Fibrosi Cistica, Università degli Studi di Napoli Federico II
Naples, Napoli
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions